Open access
Open access
Powered by Google Translator Translator

A preliminary study showed prolonged viral suppression is feasible with anti-HIV-1 antibody therapy.

18 Apr, 2022 | 10:06h | UTC

Prolonged viral suppression with anti-HIV-1 antibody therapy – Nature

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.